Evidence map›Paper›PMID 37466796›Full record

ArticleJournal of cancer research and clinical oncology2023

A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials.

Anna Fleischer, Larissa Zapf, Johannes Allgaier, Karin Jordan, Götz Gelbrich, Rüdiger Pryss, Johannes Schobel, Max Bittrich, Hermann Einsele, Martin Kortüm and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Gustatory dysfunction under talquetamab therapy in multiple myeloma: a cross-sectional study of patient-reported course, nutritional changes, and quality of life.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Patient preferences for treatment‑free intervals in multiple myeloma: mixed‑methods insights on monitoring trade‑offs and supportive care improvements.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anna Fleischer *Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080, Würzburg, Germany.
Larissa Zapf *Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080, Würzburg, Germany.
Johannes AllgaierInstitute of Biometry and Epidemiology, University Hospital of Würzburg, Würzburg, Germany.
Karin JordanDepartment of Hematology, Oncology and Palliative Medicine, Ernst Von Bergmann Hospital, Potsdam, Germany.
Götz GelbrichInstitute of Biometry and Epidemiology, University Hospital of Würzburg, Würzburg, Germany.
Rüdiger PryssInstitute of Biometry and Epidemiology, University Hospital of Würzburg, Würzburg, Germany.
Johannes SchobelDepartment of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
Max BittrichDepartment of Internal Medicine II, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080, Würzburg, Germany.
Hermann EinseleDepartment of Internal Medicine II, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080, Würzburg, Germany.
Martin KortümDepartment of Internal Medicine II, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080, Würzburg, Germany.
Imad MaatoukDepartment of Internal Medicine II, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080, Würzburg, Germany.
Niels WeinholdDepartment of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
Leo RascheDepartment of Internal Medicine II, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080, Würzburg, Germany. Rasche_L@ukw.de.

Funding

Federal Ministry of Education and Research BMBF O1KD 1906
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Endpoint measureLenalidomide maintenance therapyMultiple myelomaPatient involvementProgression-free survivalQuality of life

Identifiers

PMID37466796
PMCPMC10587328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.